Literature DB >> 9206632

[Malignant tumors of the hepatic bifurcation--results of surgical therapy and prognostic factors].

K T Beckurts1, A H Hölscher, T H Bauer, J R Siewert.   

Abstract

Between 1 January 1986 and 31 December 1994, 45 patients with carcinoma of the hepatic bifurcation underwent operations in the department of surgery. According to Bismuth's classification (1992), there were 7 type I, 4 type II, 22 type III and 12 type IV tumors. 31 of the 45 patients (68.9%) underwent surgical resections with curative intentions: resection of the hepatic bifurcation (n = 9, 29%), resection of the hepatic bifurcation with hilar liver resection (n = 7, 22.6%), resection of the hepatic bifurcation with left hemihepatectomy (n = 10, 32.3%), orthotopic liver transplantation (n = 5, 16.1%). The remaining 14 patients underwent palliative (n = 6) or diagnostic (n = 8) operations. Two of the 45 patients (4.2%) died in hospital. Histological examination demonstrated R0 resection in 17 of 31 (54.8%) of the patients, while in the remaining 14 cases, only a R1/RX resection had been achieved. One-, 2- and 5-year survival rates were 75.4%, 53.9% and 24.5% (median survival: 729 days) in the 31 resected patients, and 30.8%, 10.3% and 0% (median survival: 153 days) in the palliative treatment group. A statistically significant influence on survival could be demonstrated for nodal status (N0/N1) and residual tumor status (R0/R1, R2).

Entities:  

Mesh:

Year:  1997        PMID: 9206632     DOI: 10.1007/s001040050201

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  4 in total

1.  [Hilar cholangiocarcinoma -- results of en bloc resection of tumor and liver].

Authors:  G Otto; J Thies; M Hoppe-Lotichius; F Bittinger; M B Pitton; A Hadian
Journal:  Chirurg       Date:  2004-01       Impact factor: 0.955

2.  Extended resections for hilar cholangiocarcinoma.

Authors:  P Neuhaus; S Jonas; W O Bechstein; R Lohmann; C Radke; N Kling; C Wex; H Lobeck; R Hintze
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

3.  [Surgical therapy of hilar cholangiocarcinoma].

Authors:  H Lang; G M Kaiser; T Zöpf; G C Sotiropoulos; A Frilling; M Malagó; C E Broelsch
Journal:  Chirurg       Date:  2006-04       Impact factor: 0.955

4.  The role of liver transplantation in the treatment of hilar cholangiocarcinoma.

Authors:  Hauke Lang; Georgios C Sotiropoulos; Gernot M Kaiser; Ernesto P Molmenti; Massimo Malagó; Christoph E Broelsch
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.